NeoChord appointed Dr. Martin Leon as executive chair of the company's U.S. early feasibility study of its Transcatheter Nexus system. Leon will be responsible for overseeing and leading the company's initiatives to advance its U.S. regulatory strategy for the Nexus system. He will also guide the company's overall global regulatory strategy as … [Read more...] about NeoChord appoints executive chair to lead early feasibility study of transcatheter mitral chordal repair device
Catheters
Stereotaxis opens new headquarters in St. Louis
Surgical robotics company Stereotaxis (NYSE: STXS) is holding a grand opening today for its 45,000 ft² headquarters facility in downtown St. Louis. The new headquarters is located in the renovated historic Globe Building in St. Louis’s growing Downtown North Urban Insight District. It's an all-in-one facility housing research and development, … [Read more...] about Stereotaxis opens new headquarters in St. Louis
Silk Road Medical grows sales 33% in Q4
Silk Road Medical (NSDQ:SILK) posted fourth-quarter results that beat the revenue consensus on Wall Street and missed on earnings estimates. The Sunnyvale, California-based stroke treatment tech company reported losses of -$14.7 million, or -42¢ per share, on sales of $28.3 million for the three months ended Dec. 31, 2021, for a bottom-line gain … [Read more...] about Silk Road Medical grows sales 33% in Q4
Cardiovascular Systems, Innova Vascular partner to develop thrombectomy devices
Cardiovascular Systems (NSDQ:CSII) announced that it has partnered with Innova Vascular to develop a full line of thrombectomy devices. Under the terms of the agreement, Cardiovascular Systems (St. Paul, Minnesota) will provide financing to Innova (Irvine, California) to develop thrombectomy devices to remove blood clots from arteries and veins. … [Read more...] about Cardiovascular Systems, Innova Vascular partner to develop thrombectomy devices
LeMaitre Vascular beats The Street in Q4, grows sales 5%
LeMaitre Vascular (NSDQ:LMAT) posted fourth-quarter results that beat the overall consensus forecast on Wall Street. The Burlington, Massachusetts-based company yesterday evening reported profits of $6.2 million, or 28¢ per share, on sales of $39.5 million for the three months ended Dec. 31, 2021, for a bottom-line loss of -12.2% on sales growth … [Read more...] about LeMaitre Vascular beats The Street in Q4, grows sales 5%
Interrad Medical, Eloquest Healthcare partner to expand SecurAcath sales in U.S.
Interrad Medical this week announced that it formed a strategic partnership with Eloquest Healthcare to expand sales of SecurAcath in the U.S. Through the partnership, the companies will provide hospitals and clinicians with Interred Medical's SecurAcath to improve outcomes and reduce medical expenses, according to the company. “We are … [Read more...] about Interrad Medical, Eloquest Healthcare partner to expand SecurAcath sales in U.S.
Teleflex wins FDA clearance for expanded indications of CTO specialty catheters, guidewires
Teleflex (NYSE:TFX) today announced that it received FDA clearance for expanded indication for its specialty catheters and coronary guidewires for use in crossing chronic total occlusion percutaneous coronary interventions (CTO PCI). Devices that are included in the expanded indication are the Teleflex GuideLiner V3 catheter, TrapLiner catheter, … [Read more...] about Teleflex wins FDA clearance for expanded indications of CTO specialty catheters, guidewires
Penumbra posts mixed-bag Q4 results, grows sales 22%
Penumbra (NYSE:PEN) this week posted fourth-quarter results that beat the revenue consensus on Wall Street but missed earnings estimates. The Alameda, California-based company reported losses of -$24.6 million, or -66¢ per share, on sales of $204 million for the three months ended Dec. 31, 2021, for a sales growth of 22.24% compared with Q4 … [Read more...] about Penumbra posts mixed-bag Q4 results, grows sales 22%
InfuSystem, Solo-Dex sign distribution agreement for nerve block catheters
InfuSystem today announced that it entered a national distribution agreement with Solo-Dex for its continuous nerve block catheters. Solo-Dex's catheter over the needle technology allows anesthesiologists to place facile continuous peripheral block catheters in two to three minutes. It can be used in common procedures such as shoulder repair, … [Read more...] about InfuSystem, Solo-Dex sign distribution agreement for nerve block catheters
Medtronic wins FDA expanded approval to use cardiac cryoablation catheters in kids
Medtronic today announced that it received FDA expanded approval for its Freezor and Freezor Xtra cardiac cryoablation catheters for pediatric atrioventricular nodal reentrant tachycardia (AVRNT). AVNRT is the most common form of supraventricular tachycardia and involves a life-threatening abnormal heart rhythm. More than a third of AVRNY cases … [Read more...] about Medtronic wins FDA expanded approval to use cardiac cryoablation catheters in kids